Arcus Biosciences Stock Probability of Future Stock Price Finishing Over 25.84
Arcus Biosciences' future price is the expected price of Arcus Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Arcus Biosciences performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Please specify Arcus Biosciences' target price for which you would like Arcus Biosciences odds to be computed.
Arcus |
Arcus Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcus Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcus Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arcus Biosciences is not yet fully synchronised with the market data | |
| Arcus Biosciences generated a negative expected return over the last 90 days | |
| Arcus Biosciences has some characteristics of a very speculative penny stock | |
| Arcus Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 258 M. Net Loss for the year was (283 M) with loss before overhead, payroll, taxes, and interest of (190 M). | |
| Arcus Biosciences currently holds about 1.05 B in cash with (170 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.48. | |
| Arcus Biosciences has a poor financial position based on the latest SEC disclosures | |
| Over 83.0% of the company shares are owned by institutional investors |
Arcus Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcus Stock often depends not only on the future outlook of the current and potential Arcus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 90.1 M | |
| Cash And Short Term Investments | 978 M |
Arcus Biosciences Technical Analysis
Arcus Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Arcus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arcus Biosciences. In general, you should focus on analyzing Arcus Stock price patterns and their correlations with different microeconomic environments and drivers.
Arcus Biosciences Predictive Forecast Models
Arcus Biosciences' time-series forecasting models is one of many Arcus Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arcus Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arcus Biosciences
Checking the ongoing alerts about Arcus Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arcus Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arcus Biosciences is not yet fully synchronised with the market data | |
| Arcus Biosciences generated a negative expected return over the last 90 days | |
| Arcus Biosciences has some characteristics of a very speculative penny stock | |
| Arcus Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 258 M. Net Loss for the year was (283 M) with loss before overhead, payroll, taxes, and interest of (190 M). | |
| Arcus Biosciences currently holds about 1.05 B in cash with (170 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.48. | |
| Arcus Biosciences has a poor financial position based on the latest SEC disclosures | |
| Over 83.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Tools for Arcus Stock
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets |